Response to "Baclofen and alcohol use disorders: From miracle to mirage"

Affiliations

¹ ADAPT Lab, Department of Psychology, University of Amsterdam, Amsterdam, The Netherlands.
² Academical Medical Centre (AMC), Department of Psychiatry, University of Amsterdam, Amsterdam, The Netherlands; Amsterdam Institute for Addiction Research, Department of Psychiatry, University of Amsterdam, Amsterdam, The Netherlands; Arkin Institute for Mental Health Care, Amsterdam, The Netherlands.
³ Academical Medical Centre (AMC), Department of Psychiatry, University of Amsterdam, Amsterdam, The Netherlands; Amsterdam Institute for Addiction Research, Department of Psychiatry, University of Amsterdam, Amsterdam, The Netherlands.

Comment

Esther M Beraha et al. Eur Neuropsychopharmacol. 2017 Jul.

. 2017 Jul;27(7):693-694.

doi: 10.1016/j.euroneuro.2017.05.002. Epub 2017 May 30.

¹ ADAPT Lab, Department of Psychology, University of Amsterdam, Amsterdam, The Netherlands.
² Academical Medical Centre (AMC), Department of Psychiatry, University of Amsterdam, Amsterdam, The Netherlands; Amsterdam Institute for Addiction Research, Department of Psychiatry, University of Amsterdam, Amsterdam, The Netherlands; Arkin Institute for Mental Health Care, Amsterdam, The Netherlands.
³ Academical Medical Centre (AMC), Department of Psychiatry, University of Amsterdam, Amsterdam, The Netherlands; Amsterdam Institute for Addiction Research, Department of Psychiatry, University of Amsterdam, Amsterdam, The Netherlands.

No abstract available

Comment on

Efficacy and safety of high-dose baclofen for the treatment of alcohol dependence: A multicentre, randomised, double-blind controlled trial.
Beraha EM, Salemink E, Goudriaan AE, Bakker A, de Jong D, Smits N, Zwart JW, Geest DV, Bodewits P, Schiphof T, Defourny H, van Tricht M, van den Brink W, Wiers RW. Beraha EM, et al. Eur Neuropsychopharmacol. 2016 Dec;26(12):1950-1959. doi: 10.1016/j.euroneuro.2016.10.006. Epub 2016 Nov 11. Eur Neuropsychopharmacol. 2016. PMID: 27842939 Clinical Trial.
Baclofen and alcohol use disorders: From miracle to mirage.
Braillon A, Naudet F. Braillon A, et al. Eur Neuropsychopharmacol. 2017 Jul;27(7):691-692. doi: 10.1016/j.euroneuro.2017.05.003. Epub 2017 May 26. Eur Neuropsychopharmacol. 2017. PMID: 28552404 No abstract available.